Open access
From Fingerprint to Function: A Convergent Framework for Translational Metabolomics in Autoimmune Disease
Abstract
Autoimmune diseases are clinically heterogeneous, and patients who share a diagnosis often diverge in outcome and drug response, yet conventional biomarkers capture only part of this variation. This feature article explores how metabolomics, the molecular readout closest to the phenotype, can strengthen precision medicine across diagnosis, prediction of therapeutic response, and mechanistic understanding, and introduces a conceptual framework, the Detect-Predict-Explain triad, for prioritizing the metabolic markers most worth advancing toward the clinic.